Pfizer’s Ibrance Gets FDA Approval for Breast Cancer (PFE)
Author: Shobhit Seth / Source: Investopedia U.S. pharmaceutical giant Pfizer Inc. (PFE ) announced...
WHAT'S UP IN
Letrozole
Novartis wins FDA approval for breast cancer drug aiming for Pfizer’s Ibrance
Source: Reuters Novartis on Monday won U.S. Food and Drug Administration approval for Kisqali to...
FDA okays new drug for type of advanced breast cancer
Author: Linda A. Johnson / Source: CTVNews The logo of Swiss pharmaceutical company Novartis is...
Ribociclib Improves Survival in Post-Menopausal Women With Metastatic Breast Cancer
246,660 women will be diagnosed with breast cancer in 2016, and 40,450 women will die from the...
Ribociclib improves progression-free survival in advanced breast cancer
The addition of the CDK4/6 inhibitor ribociclib to letrozole therapy significantly improves...
